Literature DB >> 3909150

Human apolipoprotein E expression in Escherichia coli: structural and functional identity of the bacterially produced protein with plasma apolipoprotein E.

T Vogel, K H Weisgraber, M I Zeevi, H Ben-Artzi, A Z Levanon, S C Rall, T L Innerarity, D Y Hui, J M Taylor, D Kanner.   

Abstract

Human apolipoprotein E (apoE) was produced in Escherichia coli by transforming cells with an expression vector containing a reconstructed apoE cDNA, a lambda PL promoter regulated by the thermolabile cI repressor, and a ribosomal binding site derived from the lambda cII or the E. coli beta-lactamase gene. Transformed cells induced at 42 degrees C for short periods of time (less than 20 min) produced apoE, which accumulated in the cells at levels of approximately equal to 1% of the total soluble cellular protein. Longer induction periods resulted in cell lysis and the proteolytic destruction of apoE. The bacterially produced apoE was purified by heparin-Sepharose affinity chromatography, Sephacryl S-300 gel filtration, and preparative Immobiline isoelectric focusing. The final yield was approximately equal to 20% of the initial apoE present in the cells. Except for an additional methionine at the amino terminus, the bacterially produced apoE was indistinguishable from authentic human plasma apoE as determined by NaDodSO4 and isoelectric focusing gel electrophoresis, amino acid composition of the total protein as well as its cyanogen bromide fragments, and partial amino acid sequence analysis (residues 1-17 and 109-164). Both the bacterially produced and authentic plasma apoE bound similarly to apolipoprotein B,E(low density lipoprotein) receptors of human fibroblasts and to hepatic apoE receptors. Intravenous injection resulted in similar rates of clearance for both the bacterially produced and authentic apoE from rabbit and rat plasma (approximately equal to 50% removed in 20 min). The ability to synthesize a bacterially produced human apolipoprotein with biological properties indistinguishable from those of the native protein will allow the production of large quantities of apoE for use in further investigations of the biological and physiological properties of this apolipoprotein.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3909150      PMCID: PMC391503          DOI: 10.1073/pnas.82.24.8696

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Regulation of the establishment of repressor synthesis in bacteriophage lambda.

Authors:  A B Oppenheim; G Mahajna; S Koby; S Altuvia
Journal:  J Mol Biol       Date:  1982-02-25       Impact factor: 5.469

2.  Human apolipoprotein E. The complete amino acid sequence.

Authors:  S C Rall; K H Weisgraber; R W Mahley
Journal:  J Biol Chem       Date:  1982-04-25       Impact factor: 5.157

3.  Genetic control of human apolipoprotein E polymorphism: comparison of one- and two-dimensional techniques of isoprotein analysis.

Authors:  G Utermann; A Steinmetz; W Weber
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

4.  Amino acid sequence of the signal peptide of OmpF, a major outer membrane protein of Escherichia coli.

Authors:  N Mutoh; K Inokuchi; S Mizushima
Journal:  FEBS Lett       Date:  1982-01-25       Impact factor: 4.124

5.  Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms.

Authors:  K H Weisgraber; S C Rall; R W Mahley
Journal:  J Biol Chem       Date:  1981-09-10       Impact factor: 5.157

6.  Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes.

Authors:  V I Zannis; J L Breslow; G Utermann; R W Mahley; K H Weisgraber; R J Havel; J L Goldstein; M S Brown; G Schonfeld; W R Hazzard; C Blum
Journal:  J Lipid Res       Date:  1982-08       Impact factor: 5.922

Review 7.  Familial dysbetalipoproteinemia. New aspects of pathogenesis and diagnosis.

Authors:  R J Havel
Journal:  Med Clin North Am       Date:  1982-03       Impact factor: 5.456

8.  Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects.

Authors:  S C Rall; K H Weisgraber; T L Innerarity; R W Mahley
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

Review 9.  Preferential codon usage in prokaryotic genes: the optimal codon-anticodon interaction energy and the selective codon usage in efficiently expressed genes.

Authors:  H Grosjean; W Fiers
Journal:  Gene       Date:  1982-06       Impact factor: 3.688

10.  Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors.

Authors:  D Y Hui; T L Innerarity; R W Mahley
Journal:  J Biol Chem       Date:  1981-06-10       Impact factor: 5.157

View more
  20 in total

1.  Increased clearance of plasma cholesterol after injection of apolipoprotein E into Watanabe heritable hyperlipidemic rabbits.

Authors:  N Yamada; H Shimano; H Mokuno; S Ishibashi; T Gotohda; M Kawakami; Y Watanabe; Y Akanuma; T Murase; F Takaku
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Conformational flexibility in the apolipoprotein E amino-terminal domain structure determined from three new crystal forms: implications for lipid binding.

Authors:  B W Segelke; M Forstner; M Knapp; S D Trakhanov; S Parkin; Y M Newhouse; H D Bellamy; K H Weisgraber; B Rupp
Journal:  Protein Sci       Date:  2000-05       Impact factor: 6.725

Review 3.  Learning from biology: synthetic lipoproteins for drug delivery.

Authors:  Huang Huang; William Cruz; Juan Chen; Gang Zheng
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-10-24

Review 4.  The purification of eukaryotic polypeptides synthesized in Escherichia coli.

Authors:  F A Marston
Journal:  Biochem J       Date:  1986-11-15       Impact factor: 3.857

5.  Heparin- and sulfatide-binding peptides from the type I repeats of human thrombospondin promote melanoma cell adhesion.

Authors:  N H Guo; H C Krutzsch; E Nègre; T Vogel; D A Blake; D D Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

6.  Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo.

Authors:  P C Rensen; M Oosten; E Bilt; M Eck; J Kuiper; T J Berkel
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

7.  n-3, but not n-6 lipid particle uptake requires cell surface anchoring.

Authors:  Faith M Murray-Taylor; Yuan-Yuan Ho; Narumon Densupsoontorn; Chuchun L Chang; Richard J Deckelbaum; Toru Seo
Journal:  Biochem Biophys Res Commun       Date:  2010-01-07       Impact factor: 3.575

8.  Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits.

Authors:  R W Mahley; K H Weisgraber; M M Hussain; B Greenman; M Fisher; T Vogel; M Gorecki
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

9.  Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro.

Authors:  T Wisniewski; E M Castaño; A Golabek; T Vogel; B Frangione
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

10.  Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein.

Authors:  E Sehayek; U Lewin-Velvert; T Chajek-Shaul; S Eisenberg
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.